Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Zevalin ibritumomab tiuxetan (IDEC-Y2B8): Phase III testing udpate

Idec Pharmaceuticals Corp. (IDPH), San Diego, Calif.
Product: Zevalin ibritumomab

Read the full 101 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE